Fed. Circ. Tells PTAB To Look At NuVasive Patent Again

Law360 (November 9, 2018, 8:00 PM EST) -- The Federal Circuit on Friday tossed a Patent Trial and Appeal Board decision invalidating a NuVasive patent covering a procedure for spinal surgery as obvious, finding that the board had interpreted a term too broadly and sending the case back for reconsideration.

In a 27-page nonprecedential opinion, a three-judge panel vacated the PTAB's decision in inter partes re-examination of a NuVasive spinal surgery patent. In addition to interpreting too broadly a claim term for the lateral approach in which an implant was inserted in a patient's spine, the board had also erred in finding no connection between NuVasive's patent and its...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!